List of member names is provided at the end of this article.
The burden of living with an undiagnosed condition is high and includes physical and emotional suffering, frustrations, and uncertainty. For patients and families experiencing these stressors, higher levels of empowerment may be associated with better outcomes. Thus, it is important to understand the experiences of patients with undiagnosed conditions and their families affected by undiagnosed conditions in order to identify strategies for fostering empowerment. In this study, we used the Genetic Counseling Outcome Scale (GCOS-24) to assess levels of empowerment and support group participation in 35 adult participants and 67 parents of child participants in the Undiagnosed Diseases Network (UDN) prior to their UDN in-person evaluation. Our results revealed significantly lower empowerment scores on the GCOS-24 in adult participants compared to parents of child participants [t(100) = − 3.01, p = 0.003, average difference = − 11.12, 95% CI (− 3.78, − 18.46)] and no significant association between support group participation and empowerment scores. The majority of participants (84.3%, 86/102) are not currently participating in any support groups, and participation rates were not significantly different for adult participants and parents of child participants (11.4 vs. 19.7%, respectively, FE p = 0.40). Open-ended responses provided additional insight into support group participation, the challenges of living with undiagnosed conditions, and positive coping strategies. Future research will evaluate the extent to which empowerment scores change as participation in the UDN unfolds.
Bartlett, Y. K., & Coulson, N. S. (2011). An investigation into the empowerment effects of using online support groups and how this affects health professional/patient communication. Patient Education and Counseling, 83(1), 113–119. https://doi.org/10.1016/j.pec.2010.05.029. CrossRefPubMed
Bolen, S. D., Chandar, A., Falck-Ytter, C., Tyler, C., Perzynski, A. T., Gertz, A. M., et al. (2014). Effectiveness and safety of patient activation interventions for adults with type 2 diabetes: systematic review, meta-analysis, and meta-regression. Journal of General Internal Medicine, 29(8), 1166–1176. CrossRefPubMedPubMedCentral
Chen, M. F., Tsai, C. T., Hsu, S. M., Tu, S. Y., Kao, P. L., & Chen, S. L. (2013). Patient perceptions of empowerment processes, health outcomes and related factors in patients living with diabetes in Taiwan: a cross-sectional survey. Journal of Community Health Nursing, 30(4), 201–215. CrossRefPubMed
Diness, B. R., Overbeck, G., Hjortshoj, T. D., Hammer, T. B., Timshel, S., Sorensen, E., & McAllister, M. (2017). Translation and adaptation of the Genetic Counselling Outcome Scale (GCOS024) for use in Denmark. Journal of Genetic Counseling. https://doi.org/10.1007/s10897-017-0086-7. CrossRefPubMed
EURORDIS. (2018). What is a rare disease? Retrieved from http://www.eurordis.org/sites/default/files/publications/Fact_Sheet_RD.pdf Accessed 03 Jan 2018.
Finlayson, M. L., & Cho, C. C. (2011). A profile of support group use and need among middle-aged and older adults with multiple sclerosis. Journal Gerontological Social Work, 54(5), 475–493. CrossRef
McAllister, M. (2016). Genomics and patient empowerment. In D. K. R. Chadwick (Ed.), Genomics and society (pp. 39–68). Philadelphia: Elsevier. CrossRef
McConkie-Rosell, A., Hooper, S. R., Pena, L. D. M., Schoch, K., Spillmann, R. C., Jiang, Y.-H., … Shashi, V. (2018). Psychosocial profiles of parents of children with undiagnosed diseases: managing well or just managing? Journal of Genetic Counseling.
Molster, C., Urwin, D., De Pietro, L., Fookes, M., Petrie, D., van der Laan, S., & Dawkins, H. (2016). Survey of healthcare experiences of Australian adults living with rare diseases. Orphanet Journal of Rare Diseases, 11.
National Institutes of Health. (2017). FAQs about rare diseases. Retrieved from https://rarediseases.info.nih.gov/diseases/pages/31/faqs-about-rare-diseases date last updated 11/30/2017, date accessed 03 Jan 2018.
Satu, E., Kaariainen, M., Outi, K., Polkki, T., Utriainen, K., & Kyngas, H. (2014). Qualitative content analysis: a focus on trustworthiness. SAGE Open, 4, 1–10.
Schmidt, M., Eckardt, R., Scholtz, K., Neuner, B., von Dossow-Hanfstingl, V., Sehouli, J., … PERATECS Group. (2015). Patient empowerment improved perioperative quality of care in cancer patients aged >=65 years—a randomized controlled trial. PLoS One, 10(9).
Spillmann, R. C., McConkie-Rosell, A., Pena, L., Jiang, Y.-H., Undiagnosed Diseases Network, Schoch, K., et al. (2017). A window into living with an undiagnosed disease: illness narratives from the Undiagnosed Diseases Network. Orphanet Journal of Rare Diseases, 12(71).
Wallerstein, N. (2006). What is the evidence on effectiveness of empowerment to improve health?. Retrieved from Copenhage: http://www.euro.who.int/en/data-and-evidence/evidence-informed-policy-making/publications/pre2009/what-is-the-evidence-on-effectiveness-of-empowerment-to-improve-health
Zurynski, Y., Deverell, M., Dalkeith, T., Johnson, S., Christodoulou, J., Leonard, H., … APSU Rare Diseases Impacts on Families Study group. (2017). Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays. Orphanet Journal of Rare Diseases, 12.
- Understanding Adult Participant and Parent Empowerment Prior to Evaluation in the Undiagnosed Diseases Network
Christina G. S. Palmer
Ingrid A. Holm
Janet S. Sinsheimer
Lauren C. Briere
Matthew R. Herzog
Rebecca C. Spillmann
Undiagnosed Diseases Network
- Springer US